Premium
Treatment with deferasirox (Exjade ® ) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study
Author(s) -
Voskaridou Ersi,
Plata Eleni,
Douskou Maroussa,
Papadakis Manousos,
Delaki EleniEvangelia,
Christoulas Dimitrios,
Terpos Evangelos
Publication year - 2010
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2009.07930.x
Subject(s) - deferasirox , medicine , pediatrics , thalassemia